| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| D.E. Shaw David Shaw | 644K | $18.39M | NEW |
| Point72 Steve Cohen | 385K | $10.99M | NEW |
| Maverick Capital Lee Ainslie | 60K | $1.71M | NEW |
| Citadel Ken Griffin | 53K | $1.53M | NEW |
QuidelOrtho Corporation is a leading manufacturer and provider of diagnostic testing solutions that serve the healthcare industry on a global scale. The company focuses on developing innovative diagnostic products designed to detect and diagnose a variety of medical conditions with increased accuracy and efficiency. QuidelOrtho's portfolio includes rapid diagnostic tests, traditional laboratory assays, and immunoassays that are used in clinical laboratories, hospitals, and primary care environments. The key feature of QuidelOrtho's offerings lies in its emphasis on providing reliable and timely diagnosis, which helps healthcare professionals in making informed decisions for patient care. Products from QuidelOrtho cover a broad spectrum of medical areas, including infectious diseases, cardiology, women’s health, and gastrointestinal conditions, significantly impacting public health outcomes. In the financial market, QuidelOrtho Corporation plays a crucial role in the healthcare sector, especially during times of heightened health crises. The company's commitment to advancing diagnostic technologies underscores its relevance amidst rising demand for rapid and accurate testing solutions in the medical field globally.
Earnings calendar coming soon. Subscribe to get notified when QDEL reports next.
Get earnings alerts →